Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anika Therapeutics (ANIK) Income towards Parent Company (2016 - 2025)

Historic Income towards Parent Company for Anika Therapeutics (ANIK) over the last 16 years, with Q3 2025 value amounting to $846000.0.

  • Anika Therapeutics' Income towards Parent Company rose 10301.36% to $846000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.8 million, marking a year-over-year decrease of 5650.33%. This contributed to the annual value of -$47.6 million for FY2024, which is 3997.45% up from last year.
  • Per Anika Therapeutics' latest filing, its Income towards Parent Company stood at $846000.0 for Q3 2025, which was up 10301.36% from $677000.0 recorded in Q2 2025.
  • Anika Therapeutics' 5-year Income towards Parent Company high stood at $16.2 million for Q4 2023, and its period low was -$28.1 million during Q3 2024.
  • For the 5-year period, Anika Therapeutics' Income towards Parent Company averaged around -$2.3 million, with its median value being -$2.6 million (2024).
  • Examining YoY changes over the last 5 years, Anika Therapeutics' Income towards Parent Company showed a top increase of 41137.91% in 2022 and a maximum decrease of 85398.55% in 2022.
  • Quarter analysis of 5 years shows Anika Therapeutics' Income towards Parent Company stood at -$3.2 million in 2021, then surged by 411.38% to $10.1 million in 2022, then surged by 60.71% to $16.2 million in 2023, then tumbled by 219.74% to -$19.4 million in 2024, then surged by 104.37% to $846000.0 in 2025.
  • Its Income towards Parent Company was $846000.0 in Q3 2025, compared to $677000.0 in Q2 2025 and -$915000.0 in Q1 2025.